Analgesics in Guatemala

Analgesics in Guatemala

  • September 2016
  • 22 pages
  • Euromonitor International
Report ID: 207661
Analgesics registered sales of GTQ178 million in 2016, with 8% growth in current terms. Growth was driven by increased demand as consumers felt comfortable about purchasing OTC analgesics and many take them on a daily basis to treat pain and other problems. In addition, innovation was very important to growth of analgesics, as there is a wide product portfolio and consumers are looking for more-effective and faster-relief products. In 2016, Bayer de Guatemala carried out the most innovative new...

Euromonitor International’s Analgesics in Guatemala report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

ANALGESICS IN GUATEMALA
Euromonitor International
September 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2011-2016
Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Bayer De Guatemala SA in Consumer Health (guatemala)
Strategic Direction
Key Facts
Summary 1 Bayer de Guatemala SA: Key Facts
Competitive Positioning
Summary 2 Bayer de Guatemala SA: Competitive Position 2016
Laboratorios Laprin SA in Consumer Health (guatemala)
Strategic Direction
Key Facts
Summary 3 Laboratorios Laprin SA: Key Facts
Competitive Positioning
Summary 4 Laboratorios Laprin SA: Competitive Position 2016
Executive Summary
Growth in 2016
Innovation Continues To Be Common Within Consumer Health
More Dynamism Comes From International Companies
Independent Small Grocers Are Key Retailers
Strong Performance Expected Over the Forecast Period
Key Trends and Developments
Marketing Trends in Guatemala
Self-medication in Guatemala
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 9 Life Expectancy at Birth 2011-2016
Market Data
Table 10 Sales of Consumer Health by Category: Value 2011-2016
Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 14 Distribution of Consumer Health by Format: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format and Category: % Value 2016
Table 16 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 5 Research Sources












Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.

Country=Guatemala Industry=OTC ParentIndustry=Pharmaceutical Date=201609 Topic=MarketReport Publisher=EuromonitorInternational Price=1000